<DOC>
	<DOCNO>NCT02795273</DOCNO>
	<brief_summary>The purpose study evaluate safety Grass-SPIRE compare placebo evaluate treatment effect Grass-SPIRE symptom use rescue medication grass pollen season</brief_summary>
	<brief_title>Efficacy Safety Grass-SPIRE Registration Study</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Conjunctivitis</mesh_term>
	<criteria>Clinical history grass polleninduced allergic rhinitis without conjunctivitis least 2 year Score ≤ 21 RCAT questionnaire Rye grass specific IgE ≥ 0.7 kU/L Positive skin prick test Rye grass whole allergen extract History finding significant disease Asthma require GINA Step 3 high treatment History severe drug allergy , severe angioedema systemic allergic reaction Course shortduration allergyspecific immunotherapy 3 month treatment longduration allergen immunotherapy within 5 year Contraindications administration epinephrine</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Rhinitis</keyword>
	<keyword>Conjunctivitis</keyword>
	<keyword>Grass</keyword>
	<keyword>Allergy</keyword>
</DOC>